Table 1.
Statistical Significance in Pathways Mediated by miR-29s
| KEGG Pathways | Count | p Value |
|---|---|---|
| ECM-receptor interaction | 25 | <1e−325 |
| Fatty acid biosynthesis | 2 | <1e−325 |
| Viral carcinogenesis | 45 | <1e−325 |
| Fatty acid metabolism | 6 | <1e−325 |
| Amoebiasis | 23 | 2.84E−11 |
| Colorectal cancer | 23 | 5.37E−11 |
| Lysine degradation | 10 | 5.59E−10 |
| Focal adhesion | 49 | 8.93E−09 |
| Steroid biosynthesis | 3 | 2.88E−08 |
| PI3K-Akt signaling pathway | 66 | 7.95E−08 |
| p53 signaling pathway | 17 | 1.88E−07 |
| Endometrial cancer | 16 | 9.08E−07 |
| Small-cell lung cancer | 25 | 9.12E−07 |
| Fatty acid elongation | 3 | 2.21E−06 |
| Hepatitis B | 33 | 4.66E−06 |
| Pathways in cancer | 74 | 6.47E−06 |
| Hippo signaling pathway | 27 | 7.96E-05 |
| Chronic myeloid leukemia | 19 | 8.23E−05 |
| Bacterial invasion of epithelial cells | 18 | 0.0003135 |
| Pancreatic cancer | 17 | 0.000584 |
| Sulfur metabolism | 2 | 0.0016031 |
| FoxO signaling pathway | 28 | 0.0016299 |
PI3K, phosphatidylinositol 3-kinase.